High levels of dd-cfDNA identify patients with TCMR 1A and borderline allograft rejection at elevated risk of graft injury.
Stites E, Kumar D, Olaitan O, John Swanson S, Leca N, Weir M, Bromberg J, Melancon J, Agha I, Fattah H, Alhamad T, Qazi Y, Wiseman A, Gupta G.
Stites E, et al.
Am J Transplant. 2020 Sep;20(9):2491-2498. doi: 10.1111/ajt.15822. Epub 2020 Mar 10.
Am J Transplant. 2020.
PMID: 32056331
Free PMC article.